New mechanism for dysfunctional insulin release identified

September 19, 2019

In a new study, researchers at Uppsala University have identified a previously unknown mechanism that regulates release of insulin, a hormone that lowers blood glucose levels, from the β-cells (beta cells) of the pancreas. This mechanism is disrupted in type 2 diabetes. The scientists hope this finding will be used to develop new treatments against the disease.

Globally, more than 400 million people suffer from type 2 diabetes. One of the main problems is inadequate secretion, from the β-cells of the pancreas, of insulin hormone, which lowers blood sugar (blood glucose).

It has been known for some time that impaired insulin secretion is due to an inability of the insulin-containing secretory granules attach themselves ('dock') to, and then fuse with, the cell membrane. As a result, less insulin reaches the blood and, accordingly, the body becomes less able to reduce blood glucose levels sufficiently.

In the new study, the scientists identify a protein, Sac2, that is found at lower levels in patients with type 2 diabetes. In experiments, the researchers show that lowering the levels of this protein by experimental means leads to reduced insulin secretion from the β-cells. By using advanced microscopy techniques, the researchers were able to show that Sac2 is an important component on the surface of the insulin-containing secretory granules, where it modifies the fat composition of the membrane. In the absence of Sac2, a specific fat molecule accumulates on the surface of the secretory granules. This incapacitates them, so that they cannot dock to the cell membrane, which in turn causes insulin secretion to be reduced.

This study shows, first and foremost, that reduced levels of a single protein gives rise to β-cells that exhibit several defects associated with type 2 diabetes. But it also shows that the fat composition of the insulin-containing secretory granules is of importance for their ability to be released from the cells. The scientists now hope that it will be possible to use these findings to develop new ways of treating type 2 diabetes.
-end-


Uppsala University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.